Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on Most Favored Nation
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
Learn more
BIO Statement on Industry Tariffs
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
Learn more
BIO Extends Agreement with Avantor for Five…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Announces IAR – The French Bioeconomy Cluster as a Key Supporting Organization of the 2016 BIO World Congress on Industrial Biotechnology
April 4, 2016
The Biotechnology Innovation Organization (BIO) is pleased to announce that Europe’s largest cluster of bioeconomy companies, IAR, will be a top supporting organization of BIO’s 13th Annual World Congress on Industrial Biotechnology…
NexSteppe Inc. CEO Selected to Receive the 2016 BIO Rosalind Franklin Award
March 31, 2016
The Biotechnology Innovation Organization (BIO) announced today that President and CEO of NexSteppe, Anna Rath, has been selected by a committee of her peers to be the recipient of the 2016 BIO Rosalind Franklin Award. 
BIO Statement on American College of Physicians’ Prescription Drug Plan
March 30, 2016
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the American College of Physicians’ policy paper on prescription drugs.
2016 BIO World Congress on Industrial Biotechnology Exhibition Hall to Feature NSF Small Business Innovation Research Companies
March 28, 2016
The Biotechnology Innovation Organization (BIO) in partnership with the National Science Foundation (NSF) will feature Small Business Innovation Research (SBIR) funded early-stage industrial biotech companies at BIO’s 13thAnnual World…
BIO Announces Plenary Session Speakers for the 2016 World Congress on Industrial Biotechnology
March 23, 2016
The Biotechnology Innovation Organization (BIO) announces that executives, thought leaders, and government  officials will discuss applications in space, biofuels, and the renewable chemical landscape during plenary programs at…
BIO Statement on FDA and NIH Workforce Authorities Modernization Act
March 17, 2016
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:
BIO & Kentucky Life Sciences Council Support Bill Ensuring Patient Access to Interchangeable Biologic Medicines
March 17, 2016
The Biotechnology Innovation Organization (BIO) andKentucky Life Sciences Council (KLSC) today voiced support for Kentucky Senate Bill 134, legislation that properly preserves patient and physician access to accurate prescription…
J. Craig Venter, Ph.D to Receive the 2016 BIO George Washington Carver Award
March 17, 2016
The Biotechnology Innovation Organization (BIO) has officially named Dr. J. Craig Venter as the recipient of its 2016 George Washington Carver Award for innovation in industrial biotechnology. 
BIO Applauds Iowa Senate Passage of Renewable Chemical Tax Credit
March 17, 2016
The Biotechnology Innovation Organization (BIO) today applauded Iowa’s Senate for approving a new five-year production tax credit for renewable chemicals and helping to drive innovation in this new sector. Renewable chemicals will be defined in Iowa…
BIO Statement on Failure to Stop Patchwork of State GMO Labeling Laws
March 16, 2016
The U.S. Senate was unable to advance a national solution to GMO food labeling.  It is essential for Senate leaders to continue working to reach a much-needed compromise over the coming days, as failure to move forward allows costly and…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today